Takeover offer to the shareholders of Epigenomics AG
Summit Hero Holding GmbH published further information about the offer on the website www.summit-hero-angebot.de. This includes the approved offer document, which was published on June 8, 2017.
We cannot assume any liability for the content and accuracy of the information provided.
+++Epigenomics AG: Voluntary public takeover offer by Summit Hero Holding not successful+++
Berlin, July 12, 2017 – Summit Hero Holding GmbH (“bidder”) announced today that, as of expiry of the extended acceptance period at midnight (24:00 CEST) on July 7, 2017, 62.13 percent of Epigenomics outstanding shares have been tendered under the voluntary public takeover offer or were held by or attributed to the bidder. Consequently, the minimum acceptance threshold of 75.0 percent has not been reached.